Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs

Objective: Antiangiogenic therapies (tyrosine kinase inhibitors-TKI and direct anti-VEGF monoclonal antibodies) are being increasingly used in the treatment of solid tumors; hypertension represents a common side effect of these agents. Several mechanisms are involved in the development of hypertensi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cardiovasc Med
Main Authors: Coschignano, Maria Antonietta, De Ciuceis, Carolina, Agabiti-Rosei, Claudia, Brami, Valeria, Rossini, Claudia, Chiarini, Giulia, Malerba, Paolo, Famà, Francesca, Cosentini, Deborah, Muiesan, Maria Lorenza, Salvetti, Massimo, Petelca, Alina, Capellini, Sara, Arnoldi, Chiara, Nardin, Matteo, Grisanti, Salvatore, Rizzoni, Damiano, Berruti, Alfredo, Paini, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Cardiovascular Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7987651/
https://ncbi.nlm.nih.gov/pubmed/33778028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.651594
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados